ARCHIVES

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

This article is from The Cancer Letter archive.

Vol. 15 No. 16 | April 21, 1989

Download PDF Visit The Full Archive

Related Articles

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998

John Niederhuber Named Acting NCI Director.

June 2, 2006

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994